Originally broadcast June 25, 2020
VIVA is proud to present this Late-Breaking Clinical Trials Livestream, featuring previously unreleased data from the following trials:
4:35 - ILLUMENATE
16:00 - IMPERIAL
27:06 - Safety of Drug-coated Devices: Optum Medicare Database Analysis
42:12 - TOBA II BTK
55:55 - MERLION
Read data summaries for all trials here
Originally broadcast June 25, 2020VIVA is proud to present these previously-unreleased trial results as part of our Late-Breaking Clinical Trials
Read More ...
Originally broadcast June 25, 2020
VIVA is proud feature previously unreleased data from the following trials:
4:35 - ILLUMENATE 16:0
Read More ...
This special Strategies webinar focuses on CLI cases selected specifically for early-career interventionalists. Watch VIVA's expert faculty discuss tips and
Read More ...
This special Strategies webinar offers three cases selected for fellows & residents, focusing on acute, chronic, and superficial venous disease
Read More ...
This special Strategies on the Frontline webinar offers three cases selected for fellows & residents, focusing on aortic intervention.
Moderators
Read More ...
Study PI Dr. Marc Bonaca presents VOYAGER results to VIVA board members in this roundtable conversation. Our multidisciplinary panel of
Read More ...
Hear how hospitals and vascular labs are managing resources during the COVID-19 crisis, how telemedicine has been crucial to ongoing
Read More ...
Hear Dr. John Runback’s firsthand account of contracting COVID-19 while treating CLI patients.
Posted March 27, 2020
VIVA board member Dr. Peter Schneider discusses lessons learned about drug-eluting technology in 2019, and the future of DCB and DES in lower extremity revascularization.
VIVA's CLI pre-course explores the latest data and technical tips to help prevent amputations. Dr. Venita Chandra’s case presentation explores imaging options and guidelines in this critically ill population.
VIVA premiers late-breaking trial data in four sessions each year. At VIVA19, Dr. Ehrin Armstrong presented 12-month outcomes data from the TANGO trial.
See why VIVA's multidisciplinary approach continues to attract the best of the best.
With cutting-edge courses and a diverse, world-renowned faculty, VIVA is multidisciplinary education at its finest.
VIVA19 explored the latest scientific data, techniques, and technologies, led by vascular experts from around the world.
The VEINS offers a multidisciplinary educational experience tailored specifically for venous specialists. Learn more.
VIVA connects all members of the vascular healthcare team through Nurses + Techs: Life on the Frontline. Learn more.
VIVA and The VEINS are can't-miss events for fellows & residents. Learn more.
Panels of multidisciplinary experts present their toughest real-world cases and review them together with the audience, offering differing points of view and encouraging attendee engagement and Q&A.
VIVA's signature Roundtable sessions encourage lively debate on current topics and challenges, offering diverse points of view from all areas of vascular medicine and intervention.
VIVA is the global education course for vascular medicine and intervention. See why our live cases are an integral part of the VIVA attendee experience.
